Truck drivers were identified in a Gallup survey as the profession most at risk for type 2 diabetes.
CDC has selected the American Association of Diabetes Education (AADE) to work with truck drivers and ethnic groups that have limited access to the National Diabetes Prevention Program (DPP). AADE will create new sites to offer the evidence-based lifestyle change program, working with partners that include the advocacy group UnidosUS and the digital behavioral health provider Omada Health, as well as the Healthy Trucking Association of America.
Truck drivers were identified as the profession most at-risk for type 2 diabetes (T2D) in a Gallup-Sharecare survey released this summer. AADE will also target Hispanic, Native American, and African American communities, who have higher rates of T2D than whites.
The DPP is a yearlong program with a CDC-approved curriculum; it features 16 weekly core sessions, followed by a maintenance period of monthly sessions. Evidence shows the program stops prediabetes from progressing as participants make modest changes and lose 5% to 7% of body weight. In clinical trials, people with prediabetes who took part in the DPP compared with a group taking metformin were 58% less likely to progress to T2D.
This is the second time CDC has looked to AADE to scale the National DPP. Over the past 5 years, the organization has used its diabetes self-management education and support (DSMES) network to scale the DPP. A presentation at AADE’s summer meeting in 2016 outlined why the network is poised to bring diabetes prevention to all 50 states when Medicare starts reimbursement in 2018. One reason: many diabetes educators are already offering prevention services, but simply haven’t been reimbursed for them.
AADE will try to bridge gaps in areas of the South and Southwest with high rates of diabetes that lack National DPP programs. Targeted states include Alabama, Arkansas, Arizona, Georgia, Louisiana, Mississippi, New Mexico, and Texas, as well as parts of California with underserved Hispanic communities.
A proposed rule calls for Medicare to start paying for the DPP in April 2018, but CMS does not plan to include virtual providers the first year. Virtual providers have protested that CMS has plenty of evidence that these programs work just as well in reducing the risk of progression to T2D as traditional in-person programs. In its proposed rule CMS called for more testing before reimbursement would occur.
Spokesmen for both AADE and Omada Health said this was a separate project and not designed to generate data for that purpose.
“We identified a priority population, men, and designed a project that would meet their needs. Over the road truck drivers do not have consistent access to face-to-face programs,” said Matthew Eaton of AADE. “By working with Omada, we will be able to provide this population with access to a quality National Diabetes Prevention Program."
Bringing services to people with diabetes or at risk of developing the disease can be a challenge in remote areas. CDC published a study earlier this year that found a disconnect between poor, minority populations in need of DSMES and the programs themselves. A major hurdle is the limited way CMS pays for diabetes education.
Virtual providers have noted a similar pattern exists in prevention programs that have CDC recognition; they argue that a combination of virtual and in-person programs is needed to reach underserved communities as well as people in jobs who can’t show up at the same place every week.
“Innovations in technology are creating opportunities that increase access for the people with and at risk for diabetes,” AADE President Nancy D’Hondt, RPh, CDE, FAADE, said in a statement. “Virtual options are both timely and convenient for those who need it the most.”
Research Points to Potential MCIDs in Diabetes Distress Scale–17
November 29th 2023Researchers identified a value of at least 0.25 to be a minimal clinically important difference (MCID) in diabetes distress, and MCID values of 0.38 and 0.39 for emotional and interpersonal distress subscales and physician and regimen distress subscales, respectively.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
What We’re Reading: UnitedHealth Lawsuit; Fentanyl Crackdown; Global Heat Deaths Increase
November 15th 2023A class action lawsuit was filed against UnitedHealth Group and a subsidiary for allegedly using an algorithm to deny rehabilitation coverage for seriously ill patients; US and China officials are finalizing an agreement to crack down on fentanyl; a study published Tuesday projected global heat deaths to increase by 370% if no action is taken against global warming.
Read More
Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D
November 14th 2023The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Read More